Loteprednol Etabonate Gel (BID)

DRUG2 trials

Sponsors

Bausch & Lomb Incorporated

Conditions

CataractInflammationPain

Phase 3

Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

CompletedNCT01996839

Bausch & Lomb IncorporatedCataract, Inflammation, Pain

Start: 2013-12-31End: 2014-07-31Updated: 2020-09-25

Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

CompletedNCT02208297

Bausch & Lomb IncorporatedCataract, Inflammation, Pain

Start: 2014-09-30End: 2015-03-31Updated: 2020-09-25